L01XOther Antineoplastic Agents
Subgroups
- Platinum compoundsL01XA
- MethylhydrazinesL01XB
- Sensitizers used in photodynamic/radiation therapyL01XD
- Retinoids for cancer treatmentL01XF
- Proteasome inhibitorsL01XG
- Histone deacetylase (HDAC) inhibitorsL01XH
- Hedgehog pathway inhibitorsL01XJ
- Poly (ADP-ribose) polymerase (PARP) inhibitorsL01XK
- Antineoplastic cell and gene therapyL01XL
- Isocitrate dehydrogenase (IDH) inhibitorsL01XM
- Other antineoplastic agents (cont.)L01XU
- Other antineoplastic agentsL01XX
- Combinations of antineoplastic agentsL01XY
Substances
- arsenic trioxideL01XX27
- celecoxibL01XX33
- tretinoinL01XF01
- oxaliplatinL01XA03
- bortezomibL01XG01
- carboplatinL01XA02
- cisplatinL01XA01
- afliberceptL01XX44
- eribulinL01XX41
- anagrelideL01XX35
- bexaroteneL01XF03
- venetoclaxL01XX52
- aminolevulinic acidL01XD04
- selinexorL01XX66
- olaparibL01XK01
- carfilzomibL01XG02
- imetelstatL01XX80
- ivosidenibL01XM02
- ixazomibL01XG03
- romidepsinL01XH02
- sotorasibL01XX73
- vorinostatL01XH01
- glasdegibL01XJ03
- nirogacestatL01XX81
- talimogene laherparepvecL01XL02
- vorasidenibL01XM04
- adagrasibL01XX77
- alitretinoinL01XF02
- belzutifanL01XX74
- enasidenibL01XM01
- estramustineL01XX11
- lurbinectedinL01XX69
- nadofaragene firadenovecL01XL10
- pegaspargaseL01XX24
- porfimer sodiumL01XD01
- procarbazineL01XB01
- sonidegibL01XJ02
- tebentafuspL01XX75
- vismodegibL01XJ01
- altretamineL01XX03
- belinostatL01XH04
- denileukin diftitoxL01XX29
- niraparibL01XK02
- olutasidenibL01XM03
- panobinostatL01XH03
- pentostatinL01XX08
- satraplatinL01XA04
- talazoparibL01XK04
- tazemetostatL01XX72
- temoporfinL01XD05